The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DURTRERAD: A phase II open-label study evaluating feasibility and efficacy of durvalumab (D) and durvalumab plus tremelimumab (DT) in combination with radiotherapy (RT) in non-resectable locally advanced HPV-negative head and neck squamous cell carcinoma (LA-HNSCC).
 
Ulrich Keilholz
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck KGaA; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD Oncology
Speakers' Bureau - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Pfizer (Inst)
 
Thomas Christoph Gauler
No Relationships to Disclose
 
Carmen Stromberger
No Relationships to Disclose
 
Grzegorz Kofla
No Relationships to Disclose
 
Maike de Wit
Employment - Vivantes Network for Health
Speakers' Bureau - AstraZeneca; Ipsen; Janssen; Sanofi
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genzyme (Inst); Ipsen (Inst); Janssen (Inst); MorphoSys (Inst); MSD (Inst); Noona Healthcare (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Pierre Fabre (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Pfizer; Takeda
 
Ramona Mette
No Relationships to Disclose
 
Susen Burock
Research Funding - Miltenyi Biotec
 
Konrad Friedrich Klinghammer
Honoraria - Bristol-Myers Squibb/Celgene; Merck Serono; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono; MSD Oncology